Michael Althaus

411 total citations
39 papers, 273 citations indexed

About

Michael Althaus is a scholar working on Neurology, Physiology and Surgery. According to data from OpenAlex, Michael Althaus has authored 39 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Neurology, 9 papers in Physiology and 8 papers in Surgery. Recurrent topics in Michael Althaus's work include Botulinum Toxin and Related Neurological Disorders (25 papers), Pain Mechanisms and Treatments (9 papers) and Neurological disorders and treatments (8 papers). Michael Althaus is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (25 papers), Pain Mechanisms and Treatments (9 papers) and Neurological disorders and treatments (8 papers). Michael Althaus collaborates with scholars based in Germany, United States and Poland. Michael Althaus's co-authors include A Gressner, Angelika Hanschmann, J. Rauterberg, Astrid Scheschonka, Thomas Klein, Walter Magerl, Rolf‐Detlef Treede, Marta Banach, Pawel J. Jastreboff and Hans J. Moebius and has published in prestigious journals such as Gastroenterology, Neurology and Journal of Hepatology.

In The Last Decade

Michael Althaus

35 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Althaus Germany 10 101 44 39 38 36 39 273
Anne Sutherland United States 5 30 0.3× 49 1.1× 46 1.2× 41 1.1× 10 0.3× 14 303
Antanas Vaitkus Lithuania 9 88 0.9× 39 0.9× 11 0.3× 21 0.6× 13 0.4× 38 261
Yves Starreveld Canada 10 87 0.9× 50 1.1× 17 0.4× 80 2.1× 39 1.1× 34 372
Y. K. Kim South Korea 10 155 1.5× 72 1.6× 4 0.1× 75 2.0× 29 0.8× 18 338
Stacy V. Smith United States 9 122 1.2× 19 0.4× 20 0.5× 7 0.2× 25 0.7× 25 348
Norio Tanahashi Japan 9 87 0.9× 55 1.3× 4 0.1× 35 0.9× 18 0.5× 20 240
Guido Böning Germany 11 51 0.5× 17 0.4× 11 0.3× 70 1.8× 17 0.5× 14 357
Claudia Zawinka Austria 16 73 0.7× 56 1.3× 6 0.2× 41 1.1× 22 0.6× 27 697
Byung I. Lee South Korea 9 78 0.8× 25 0.6× 8 0.2× 81 2.1× 8 0.2× 9 365
Akiva Feintuch Canada 7 72 0.7× 19 0.4× 4 0.1× 41 1.1× 58 1.6× 9 393

Countries citing papers authored by Michael Althaus

Since Specialization
Citations

This map shows the geographic impact of Michael Althaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Althaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Althaus more than expected).

Fields of papers citing papers by Michael Althaus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Althaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Althaus. The network helps show where Michael Althaus may publish in the future.

Co-authorship network of co-authors of Michael Althaus

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Althaus. A scholar is included among the top collaborators of Michael Althaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Althaus. Michael Althaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Munin, Michael C., Alessio Baricich, Stefano Carda, et al.. (2025). Efficacy and Safety of IncobotulinumtoxinA in Older Patients with Upper Limb Spasticity: A Pooled Analysis. Geriatrics. 10(6). 155–155.
2.
Jost, Wolfgang H., Petr Kaňovský, Michael A. Hast, et al.. (2023). Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults. Toxins. 15(6). 353–353. 1 indexed citations
3.
Albanese, Alberto, Jörg Wissel, Wolfgang H. Jost, et al.. (2023). Pain Reduction in Cervical Dystonia Following Treatment with IncobotulinumtoxinA: A Pooled Analysis. Toxins. 15(5). 333–333. 6 indexed citations
4.
Molteni, Franco, Jörg Wissel, Klemens Fheodoroff, et al.. (2023). Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis. Toxins. 16(1). 19–19. 2 indexed citations
5.
Bonfert, Michaela, Florian Heinen, Petr Kaňovský, et al.. (2022). Spasticity-related pain in children/adolescents with cerebral palsy. Part 2: IncobotulinumtoxinA efficacy results from a pooled analysis. Journal of Pediatric Rehabilitation Medicine. 16(1). 83–98. 5 indexed citations
6.
Kaňovský, Petr, Elie P. Elovic, Angelika Hanschmann, et al.. (2021). Duration of Treatment Effect Using IncobotulinumtoxinA for Upper-limb Spasticity: A Post-hoc Analysis. Frontiers in Neurology. 11. 615706–615706. 2 indexed citations
7.
8.
Kaňovský, Petr, Elie P. Elovic, Michael C. Munin, et al.. (2020). Sustained efficacy of incobotulinumtoxina repeated injections for upper-limb post-stroke spasticity: A post hoc analysis. Journal of Rehabilitation Medicine. 53(1). jrm00138–jrm00138. 4 indexed citations
9.
Mitsikostas, Dimos D., et al.. (2020). IncobotulinumtoxinA for the Treatment of Blepharospasm in Toxin-Naïve Subjects: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial. Advances in Therapy. 37(10). 4249–4265. 7 indexed citations
10.
Jog, Mandar, J. Jack Lee, Astrid Scheschonka, et al.. (2020). Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study. Toxins. 12(12). 807–807. 21 indexed citations
11.
Wissel, J., Djamel Bensmaïl, Astrid Scheschonka, et al.. (2018). Efficacy and safety of incobotulinumtoxinA in the treatment of shoulder spasticity due to cerebral causes. Annals of Physical and Rehabilitation Medicine. 61. e357–e357. 1 indexed citations
12.
13.
Suckfüll, M., Michael Althaus, Barbara Ellers‐Lenz, et al.. (2011). A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus. PubMed. 11(1). 1–1. 39 indexed citations
14.
Klein, Thomas, Walter Magerl, Angelika Hanschmann, Michael Althaus, & Rolf‐Detlef Treede. (2007). Antihyperalgesic and analgesic properties of the N‐methyl‐d‐aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia. European Journal of Pain. 12(1). 17–29. 25 indexed citations
15.
16.
Rauterberg, J., et al.. (1993). Collagens in Atherosclerotic Vessel Wall Lesions. Current topics in pathology. 87. 163–192. 19 indexed citations
17.
Roessner, Albert, et al.. (1991). Joint occurrence of collagen mRNA containing cells and macrophages in human atherosclerotic vessels. Atherosclerosis. 86(1). 55–68. 17 indexed citations
18.
Jaeger, Erich, Steve Rust, Karin Scharffetter, et al.. (1990). Localization of cytoplasmic collagen mRNA in human aortic coarctation: mRNA enhancement in high blood pressure-induced intimal and medial thickening.. Journal of Histochemistry & Cytochemistry. 38(9). 1365–1375. 9 indexed citations
19.
Gressner, Axel M. & Michael Althaus. (1990). Effects of murine recombinant interferon-gamma on rat liver fat storing cell proliferation, cluster formation and proteoglycan synthesis. Biochemical Pharmacology. 40(9). 1953–1962. 6 indexed citations
20.
Gressner, A & Michael Althaus. (1988). Effects of ethanol, acetaldehyde, and lactate on proteoglycan synthesis and proliferation of cultured rat liver fat-storing cells. Gastroenterology. 94(3). 797–807. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Sutherland Breakdown of academic impact, for papers by Antanas Vaitkus Breakdown of academic impact, for papers by Yves Starreveld Breakdown of academic impact, for papers by Y. K. Kim Breakdown of academic impact, for papers by Stacy V. Smith Breakdown of academic impact, for papers by Norio Tanahashi Breakdown of academic impact, for papers by Guido Böning Breakdown of academic impact, for papers by Claudia Zawinka Breakdown of academic impact, for papers by Byung I. Lee Breakdown of academic impact, for papers by Akiva Feintuch
Rankless by CCL
2026